Clinical Trial: A Study to Evaluate the Efficacy and Safety of Long-term Administration of K-CAB Tab./K-CAB ODT(Tegoprazan) 25 mg as Maintenance Therapy Following the Treatment of GERD

U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07920679) titled 'A Study to Evaluate the Efficacy and Safety of Long-term Administration of K-CAB Tab./K-CAB ODT(Tegoprazan) 25 mg as Maintenance Therapy Following the Treatment of GERD' on Nov. 02.

Brief Summary: This study aims to assess heartburn and acid regurgitation symptoms during long-term administration of K-CAB Tab/K-CAB ODT(Tegoprazan) 25 mg in patients with GERD in routine clinical practice. The study will also evaluate safety information, including important potential risks.

Study Start Date: Aug. 14, 2025

Study Type: OBSERVATIONAL

Condition: Maintenance Therapy Following Treatment for Gastroesophageal Reflux Disease(GERD)

Recruitme...